Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, today announced an expansion of its Bio+Tech Center to support the continued growth of life sciences entrepreneurship across the region.
Activation Capital today announced enhancements to Frontier BioHealth, building on the program’s successful 2024 launch and inaugural cohort while reinforcing its broader continuum of life sciences entrepreneurship programs designed to help science-driven companies progress toward commercialization and investor readiness.
FOR IMMEDIATE RELEASE RICHMOND, Va., January 15, 2026 – Elizabeth Anne Whalley, BSN, RN, MBA, JD, CHC, CHRC, has been appointed to the board of the
The Central Virginia region is continuing to expand its BioHealth entrepreneurship and community development activities thanks to a multimillion-dollar award from the Commonwealth’s GO Virginia economic development program and close partnerships between the Virginia Biotech Research Park Authority (VBRPA), its nonprofit affiliate (Activation Capital), Virginia Commonwealth University, Richmond’s GROW Capital Jobs, and area economic development organizations.
Richmond, VA – February 18, 2025 – Activation Capital announced today that Jim Pannucci, PhD, Vice President of Entrepreneurship and Ecosystem Development, has been honored as BioBuzz’s 2024
Governor Glenn Youngkin has appointed Paul Nolde to the board of the Virginia Biotechnology Research Partnership Authority. As a political subdivision of the Commonwealth, the Authority Board works to grow the regional innovation economy.
The inaugural Frontier BioHealth Showcase, hosted by Activation Capital, brought together 10 high-potential life science startups, regional leaders, and national investors at Main Street Station on November 20, 2024.
Activation Capital, an innovation ecosystem development organization, today announced Governor Glenn Youngkin’s appointment of Brian Anderson and Barrett E. Clark to the board of the Virginia Biotechnology Research Partnership Authority (dba Activation Capital).
Ten innovative life sciences and healthtech companies enter 16-week accelerator.
New biohealth pre-accelerator program offers early-stage biotech founders’ essential skills and guidance to prepare for advanced stages, fostering innovation in the growing life sciences sector.
